Your session is about to expire
← Back to Search
Sugammadex for Improved Bowel Function After Surgery (STIM_Bowel Trial)
STIM_Bowel Trial Summary
This trial will compare the effects of two drugs given to reverse paralysis after surgery - one has no effect on bowel function, while the other does.
STIM_Bowel Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSTIM_Bowel Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STIM_Bowel Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot receive muscle relaxants due to health reasons.I am scheduled for surgery with general anesthesia through a breathing tube.My liver tests are not more than twice the normal limit.I am 18 years old or older.I cannot give consent for surgery or anesthesia.I am currently taking Toremifene.My surgery is scheduled in the South Operating Rooms at OHSU.You are allergic to the drug being tested.My kidney function is severely reduced.My surgery is planned for a weekday.I am scheduled for or have had colorectal surgery.You are pregnant.
- Group 1: Sugammadex
- Group 2: Neostigmine
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the upper limit for participants in this clinical research?
"Correct. According to clinicaltrials.gov, this medical experiment which was initially posted on March 16th 2021 is still in the process of seeking patient volunteers. 1 centre requires 120 people for participation purposes. The details were most recently amended on September 22nd 2022."
What maladies are typically alleviated by Sugammadex?
"Sugammadex is a viable solution for the resolution of neuromuscular blockade, post-operative intestinal atony, and denture retention."
Has the FDA sanctioned Sugammadex for medical applications?
"The safety rating of Sugammadex received a score of 3 as it has been tested and approved for use in Phase 4 trials."
Are enrollment opportunities still available for this research study?
"Affirmative. According to the information on clinicaltrials.gov, this trial is actively enrolling participants with an original post date of March 16th 2021 and most recent update from September 22nd 2022. A total of 120 patients are being accepted at a single medical facility."
Are there any preexisting studies that demonstrate the efficacy of Sugammadex?
"Presently, 15 ongoing investigations are examining the efficacy of sugammadex with 1 in Phase 3. Not only is Rochester, Minnesota running trials for Sugammadex but 51 sites across the nation have opened up studies as well."
Share this study with friends
Copy Link
Messenger